BRMS1 and pancreatic neoplasm: While we do not know whether miR-146 induction by BRMS1 also occurs in PDAC, it is known that miR-146 is overexpressed in pancreatic cancer vs. both normal pancreas and pancreatitis, suggesting that miR-146 has an oncogenic role in pancreatic cancer [29].